Notice: 

Direct orders are not currently available. Due to different customs policies in different countries, we need to confirm whether shipment is possible.  Product customized services is supported. Discounts & free shipping for bulk order.

Please contact Omizzur team to share with us the quantity, size, delivery address to assist you in completing order.

>> Inquiry by mail: [email protected]

>> WhatsApp:+8615619437708

Omizzur Hot Retatrutide Peptide Supplier | Hot Selling Products in 2025

Retatrutide Background

Globally, over 507 million people suffer from type 2 diabetes, and 890 million suffer from obesity. The glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR) are key regulators of blood glucose homeostasis.

The GLP-1R promotes insulin release, inhibits glucagon secretion, reduces appetite, and lowers blood glucose and body weight. The GIPR increases insulin secretion when blood glucose is elevated and stimulates glucagon release when blood glucose is low, playing a role in lipid metabolism. The GCGR regulates hepatic glucose, lipid, and protein metabolism.

Currently, the most effective treatments include GLP-1R agonists such as semaglutide and the GLP-1R/GIPR dual agonist tirzepatide. These drugs work by activating key receptors that regulate blood glucose homeostasis; however, these drugs do not target the GCGR. 

Omizzur is an ISO/GMP certified retatrutide peptide supplier with fast shipping worldwide. For inquiries/orders, please mail: [email protected]

Research Highlights

In recent years, a drug called retatrutide (also known as LY3437943) has demonstrated remarkable efficacy in the treatment of obesity through triple activation of GLP-1R, GIPR, and GCGR. Compared to the corresponding endogenous peptide, retatrutide is 8.9-fold more potent at GIPR and 0.3-fold and 0.4-fold less potent at GCGR and GLP1R, respectively.

Retatrutide has demonstrated significant potential in the treatment of obesity and metabolic diseases. Its unique molecular structure not only enhances drug stability and bioavailability but also significantly prolongs its half-life, enabling its excellent clinical performance. With further research and development, retatrutide is expected to become a rising star in the coming years, bringing benefits to millions of patients worldwide.

Retatrutide is a peptide being developed for the treatment of obesity and type 2 diabetes. It is based on the GLP/GI dual receptor agonist Tirzepatide and uses a hybrid glucagon (Gcg)-related structure to achieve triple (GLP-1/GIP/Gcg) agonist effects. This active compound can activate receptor agonists in our bodies, helping to control blood sugar and manage weight loss.

Retatrutide peptide sequence:

H-Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-{20diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

Omizzur retatrutide peptide supplier | Retatrutide data

Storage:

Short term: Refrigerate at 2°C to 8°C (36°F to 46°F)

Long term: Freeze at  -30°C to -20°C (-22°F to 4°F)

Shipping: Usually we shipped by Fedex / DHL, the arrival time is about 7-10 days, we will provide you with the tracking number after the goods are shipped.

 Order Retatrutide peptide now:

 1. Click to send inqauiry online:  Make Inquiry Now 

 2. Send mail to us: [email protected]

  * Please mail us your address and quantity needed, Omizzur services will get back to you within 1~2 hours.

About Omizzur Ltd

Omizzur specializes in custom peptide synthesis, providing professional peptide synthesis services to pharmaceutical R&D companies worldwide. Our product offerings include pharmaceutical-grade peptides, cosmetic peptides, peptide impurity synthesis, and amino acid derivatives. For more peptide product information, please contact Omizzur custom peptide synthesis.